| On-demand preexposure prophylaxis in men at high risk for HIV-1 infection JM Molina, C Capitant, B Spire, G Pialoux, L Cotte, I Charreau, ... New England Journal of Medicine 373 (23), 2237-2246, 2015 | 1847 | 2015 |
| Maraviroc for previously treated patients with R5 HIV-1 infection RM Gulick, J Lalezari, J Goodrich, N Clumeck, E DeJesus, A Horban, ... New England Journal of Medicine 359 (14), 1429-1441, 2008 | 926 | 2008 |
| Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men M Mary-Krause, L Cotte, A Simon, M Partisani, D Costagliola, ... Aids 17 (17), 2479-2486, 2003 | 673 | 2003 |
| Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients V Soumelis, I Scott, F Gheyas, D Bouhour, G Cozon, L Cotte, L Huang, ... Blood, The Journal of the American Society of Hematology 98 (4), 906-912, 2001 | 517 | 2001 |
| Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study JM Molina, I Charreau, B Spire, L Cotte, J Chas, C Capitant, C Tremblay, ... The lancet HIV 4 (9), e402-e410, 2017 | 492 | 2017 |
| Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus–infected patients: a case-control study nested within the French … S Lang, M Mary-Krause, L Cotte, J Gilquin, M Partisani, A Simon, ... Archives of internal medicine 170 (14), 1228-1238, 2010 | 374 | 2010 |
| No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception L Mandelbrot, R Tubiana, J Le Chenadec, C Dollfus, A Faye, E Pannier, ... Clinical Infectious Diseases 61 (11), 1715-1725, 2015 | 359 | 2015 |
| Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population S Lang, M Mary-Krause, L Cotte, J Gilquin, M Partisani, A Simon, ... Aids 24 (8), 1228-1230, 2010 | 347 | 2010 |
| Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial JM Molina, I Charreau, C Chidiac, G Pialoux, E Cua, C Delaugerre, ... The Lancet Infectious Diseases 18 (3), 308-317, 2018 | 298 | 2018 |
| Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America Antiretroviral Therapy Cohort Collaboration Clinical Infectious Diseases 41 (12), 1772-1782, 2005 | 291 | 2005 |
| Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection L Cotte, M Rabodonirina, F Chapuis, F Bailly, F Bissuel, C Raynal, ... Journal of Infectious Diseases 180 (6), 2003-2008, 1999 | 248 | 1999 |
| Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority … JM Molina, K Squires, PE Sax, P Cahn, J Lombaard, E DeJesus, MT Lai, ... The lancet HIV 5 (5), e211-e220, 2018 | 224 | 2018 |
| HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals S Lang, M Mary-Krause, A Simon, M Partisani, J Gilquin, L Cotte, ... Clinical Infectious Diseases 55 (4), 600-607, 2012 | 184 | 2012 |
| Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapy F Bissuel, F Bruneel, F Habersetzer, D Chassard, L Cotte, M Chevallier, ... Journal of internal medicine 235 (4), 367-372, 1994 | 178 | 1994 |
| Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus—infected patients G Chêne, E Angelini, L Cotte, JM Lang, P Morlat, C Rancinan, T May, ... Clinical Infectious Diseases 34 (5), 649-657, 2002 | 145 | 2002 |
| Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal Antiretroviral Therapy Cohort Collaboration (ART-CC) Clinical infectious diseases 48 (8), 1138-1151, 2009 | 141 | 2009 |
| Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome B Dautzenberg, T Saint Marc, MC Meyohas, M Eliaszewitch, F Haniez, ... Archives of internal medicine 153 (3), 368-372, 1993 | 135 | 1993 |
| Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat … C Orkin, JM Molina, E Negredo, JR Arribas, J Gathe, JJ Eron, ... The Lancet HIV 5 (1), e23-e34, 2018 | 126 | 2018 |
| Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission A Cheret, C Bacchus-Souffan, V Avettand-Fenoël, A Mélard, G Nembot, ... Journal of Antimicrobial Chemotherapy 70 (7), 2108-2120, 2015 | 119 | 2015 |
| Prevalence of intestinal protozoans in French patients infected with HIV L Cotte, M Rabodonirina, MA Piens, M Perreard, M Mojon, C Trepo JAIDS Journal of Acquired Immune Deficiency Syndromes 6 (9), 1024-1029, 1993 | 112 | 1993 |
